Wanleng Deng

4.1k total citations
20 papers, 1.4k citations indexed

About

Wanleng Deng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wanleng Deng has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Wanleng Deng's work include Melanoma and MAPK Pathways (6 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Estrogen and related hormone effects (3 papers). Wanleng Deng is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Estrogen and related hormone effects (3 papers). Wanleng Deng collaborates with scholars based in United States, Australia and United Kingdom. Wanleng Deng's co-authors include Michael A. Davies, Y.N. Vashisht Gopal, Gordon B. Mills, Steffi Oesterreich, Adrian V. Lee, Scott E. Woodman, Xiaojiang Cui, Paul D. Smith, Kakajan Komurov and Prahlad T. Ram and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Annals of Surgery.

In The Last Decade

Wanleng Deng

20 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wanleng Deng United States	14	907	659	272	236	186	20	1.4k
Teresa Klinowska United Kingdom	22	1.3k 1.4×	717 1.1×	419 1.5×	252 1.1×	216 1.2×	62	2.0k
Joel Morris United States	12	1.4k 1.5×	1.2k 1.7×	373 1.4×	323 1.4×	124 0.7×	31	1.9k
Edward Rosfjord United States	19	938 1.0×	1.0k 1.6×	383 1.4×	271 1.1×	128 0.7×	39	1.9k
Christina W. Yde Denmark	22	655 0.7×	458 0.7×	188 0.7×	323 1.4×	223 1.2×	59	1.2k
Brian Higgins United States	14	1.2k 1.3×	444 0.7×	436 1.6×	198 0.8×	113 0.6×	26	1.6k
Teeru Bihani United States	14	530 0.6×	388 0.6×	353 1.3×	210 0.9×	305 1.6×	27	1.1k
Yasir H. Ibrahim United States	12	1.1k 1.2×	828 1.3×	305 1.1×	249 1.1×	140 0.8×	22	1.6k
Joan T. Garrett United States	19	1.2k 1.3×	1.1k 1.7×	392 1.4×	229 1.0×	89 0.5×	30	2.0k
Ariella B. Hanker United States	15	942 1.0×	759 1.2×	445 1.6×	453 1.9×	157 0.8×	41	1.6k
Donata Vitagliano Italy	19	920 1.0×	1.0k 1.6×	390 1.4×	228 1.0×	163 0.9×	29	1.9k

Countries citing papers authored by Wanleng Deng

Since Specialization

Citations

This map shows the geographic impact of Wanleng Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanleng Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanleng Deng more than expected).

Fields of papers citing papers by Wanleng Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanleng Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanleng Deng. The network helps show where Wanleng Deng may publish in the future.

Co-authorship network of co-authors of Wanleng Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Wanleng Deng. A scholar is included among the top collaborators of Wanleng Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanleng Deng. Wanleng Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fischer, Grant M., Renato Guerrieri, Qianghua Hu, et al.. (2021). Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases. Neuro-Oncology Advances. 3(1). vdaa177–vdaa177. 13 indexed citations

Chen, Huiqin, et al.. (2018). ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity, Cellular Phenotypes, and Biochemical Properties. Molecular Cancer Research. 16(11). 1724–1736. 76 indexed citations

Goedert, Lucas, Cristiano Gonçalves Pereira, Jason Roszik, et al.. (2016). RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma. Oncotarget. 7(24). 36711–36718. 28 indexed citations

Bradley, Sherille D., Zeming Chen, Brenda Melendez, et al.. (2015). BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma. Cancer Immunology Research. 3(6). 602–609. 124 indexed citations

Gopal, Y.N. Vashisht, Helen Rizos, Guo Chen, et al.. (2014). Inhibition of mTORC1/2 Overcomes Resistance to MAPK Pathway Inhibitors Mediated by PGC1α and Oxidative Phosphorylation in Melanoma. Cancer Research. 74(23). 7037–7047. 148 indexed citations

Chen, Guo, Nitin Chakravarti, Kimberly Aardalen, et al.. (2014). Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target. Clinical Cancer Research. 20(21). 5537–5546. 120 indexed citations

Turley, Ryan S., Yoshihiro Tokuhisa, Michael E. Lidsky, et al.. (2014). Targeting N-cadherin Increases Vascular Permeability and Differentially Activates AKT in Melanoma. Annals of Surgery. 261(2). 368–377. 12 indexed citations

Davies, Michael A., Patricia S. Fox, Nicholas E. Papadopoulos, et al.. (2012). Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma. Clinical Cancer Research. 18(4). 1120–1128. 39 indexed citations

Park, Eun Sung, Rosalia Rabinovsky, Mark Carey, et al.. (2010). Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set. Molecular Cancer Therapeutics. 9(2). 257–267. 71 indexed citations

10.

Gopal, Y.N. Vashisht, Wanleng Deng, Scott E. Woodman, et al.. (2010). Basal and Treatment-Induced Activation of AKT Mediates Resistance to Cell Death by AZD6244 (ARRY-142886) in Braf- Mutant Human Cutaneous Melanoma Cells. Cancer Research. 70(21). 8736–8747. 177 indexed citations

11.

Rowe, R. W., F. R. Strebel, Wanleng Deng, et al.. (2010). Fever-range whole body thermotherapy combined with oxaliplatin: A curative regimen in a pre-clinical breast cancer model. International Journal of Hyperthermia. 26(6). 565–576. 14 indexed citations

12.

Davies, Michael A., Katherine Stemke‐Hale, E. Lin, et al.. (2009). Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma. Clinical Cancer Research. 15(24). 7538–7546. 159 indexed citations

13.

Strebel, F. R., et al.. (2006). Effect of oxaliplatin combined with fever-range whole-body thermal-therapy in a rat mammary adenocarcinoma in vivo. Cancer Research. 66. 905–905. 1 indexed citations

14.

Townson, Steven M., Adrian V. Lee, Wanleng Deng, et al.. (2003). SAFB2, a New Scaffold Attachment Factor Homolog and Estrogen Receptor Corepressor. Journal of Biological Chemistry. 278(22). 20059–20068. 75 indexed citations

15.

Cui, Xiaojiang, Ping Zhang, Wanleng Deng, et al.. (2003). Insulin-Like Growth Factor-I Inhibits Progesterone Receptor Expression in Breast Cancer Cells via the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway: Progesterone Receptor as a Potential Indicator of Growth Factor Activity in Breast Cancer. Molecular Endocrinology. 17(4). 575–588. 195 indexed citations

16.

Oesterreich, Steffi, Wanleng Deng, Shiming Jiang, et al.. (2003). Estrogen-mediated down-regulation of E-cadherin in breast cancer cells.. PubMed. 63(17). 5203–8. 84 indexed citations

17.

Deng, Wanleng, Yoshihiro Ohmori, & Thomas A. Hamilton. (1996). LPS Does Not Directly Induce STAT Activity in Mouse Macrophages. Cellular Immunology. 170(1). 20–24. 11 indexed citations

18.

Wu, Chaoqun, Wanleng Deng, Yoshihiro Ohmori, & Thomas A. Hamilton. (1996). Differential mechanisms of LPS-induced NFκB activation in macrophages and fibroblasts. Journal of Endotoxin Research. 3(1). 9–18. 3 indexed citations

19.

Zhang, Haichao, et al.. (1991). Purification and characterization of recombinant mouse thymidylate synthase. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1077(1). 35–46. 8 indexed citations

20.

Zhang, Haichao, et al.. (1990). Site-directed mutagenesis of mouse thymidylate synthase: Alteration of Arg 44 to Val 44 in a conserved loop guarding the active site has striking effects on catalysis and nucleotide binding. Biochemical and Biophysical Research Communications. 167(3). 869–875. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact